First ever NICE guidance on cannabis-based medicinal products

18 November, 2019 | Posted in: ,

NICE has published its first ever guidance on cannabis-based medicinal products. NG144 has just been published this November and outlines guidance across 4 key areas (fig 1): chemotherapy-induced nausea and vomiting, chronic pain, spasticity, and treatment-resistant epilepsy.  The National Council of Health and Care Excellence (NICE) have examined the evidence for the use of both […]

Continue Reading »

The Neurology Academy adds epilepsy and headache to the fold

19 December, 2018 | Posted in: ,

Since its inception sixteen years ago with the Parkinson’s MasterClass, the Neurology Academy has been leading the way for practically applicable education for healthcare professionals. We are proud to be expanding that range of educational offerings across a broadening range of professionals and specialisms. The past few years have seen us opening Academies for specific […]

Continue Reading »